• Research Associate, Proteomics Reagent

    Job Locations US-CA-South San Francisco
    Req No.
    Research & Development
  • Job Description


    Fluidigm is looking for a Research Associate to join our Proteomics Reagent Development Group. The successful candidate will characterize antibodies for use on Fluidigm’s new Imaging Mass Cytometry platform.


    You Are:

    • Passionate about working for a company that creates cutting edge scientific solutions
    • Inspired by the opportunity to help develop high quality reagents for Fluidigm’s new imaging platform.

    You Will:

    • Perform validation studies on new metal-conjugated antibody products for use with our novel Imaging Mass cytometry (IMC) technology
    • Perform antigen retrieval and immunostaining on FFPE and frozen tissue sections
    • Image stained tissues using immunofluorescence and IMC laser ablation
    • Prepare reports for internal and external review
    • Interface with cross functional work teams such as Research & Development, Reagent Manufacturing, and Quality Assurance
    • Maintain records and laboratory environment to comply with regulatory requirements, good laboratory practices, and standard operating procedures
    • Maintain manufacturing instruments and other laboratory equipment as needed



    You Have:

    • Minimum of 1-3 years of laboratory experience in the Biotech industry required
    • Previous work experience performing immunostaining of FFPE tissue sections required
    • Prior experience with immunofluorescence and/or Mass Cytometry a plus
    • Working knowledge of MS Office, Excel, Powerpoint
    • Ability to pick up new technologies quickly and ultimately troubleshoot independently
    • Ability to multitask in a fast-paced, teamwork-oriented environment



    Sound good? Apply online now with your resume.


    Fluidigm is an equal opportunity/affirmative action employer. We will consider all qualified applicants for employment without regard to race, color, religion, sex, age, or national origin.



    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed